Pharmaceutical Technology's In the Lab eNewsletter
May 01, 2019
Features
14
5
To achieve high-quality pharmaceutical product, it is important to characterize the drug particles and understand the behavior of bulk powder.
May 01, 2019
Features
14
5
Glycosylation modeling is a useful tool for determining biopharma product quality, and establishing collaboration between academic and industrial groups ensures that such modeling tools are fit for use.
May 01, 2019
New Technology
14
5
The EXcell 231 and EXcell 241 sensors from EXNER Process Equipment have updated software and connection features for improved flexibility and safety.
May 01, 2019
New Technology
14
5
Cygnus Technologies has developed the EndonucleaseGTP ELISA Kit to quantitate and detect residual endonuclease impurities in recombinant vaccines and viral vectors used for gene therapy.
April 26, 2019
New Technology
14
5
Lonza’s fully automated plate-based PyroTec PRO Robotic Solution accelerates endotoxin testing of parenteral pharmaceuticals.
April 24, 2019
News
14
5
University of Southern California scientists have made an advancement in chimeric antigen receptor (CAR) T-cell therapy that seems to eliminate its severe side effects, making the treatment safer and potentially available in outpatient settings.
April 23, 2019
News
14
5
Cambrex’s expanded quality control laboratory supports generic API development.
April 18, 2019
News
14
5
The agency provides recommendations for the development of bispecific antibody development programs that include regulatory, quality, nonclinical, and clinical considerations.
April 16, 2019
News
14
5
The companies will merge to offer a broader range of analytical data packages and regulatory support for biopharmaceuticals.
April 12, 2019
News
14
5
The companies will join forces on a research project to develop end-to-end workflows for the preparation, characterization, and monitoring of biotherapeutics using liquid chromatography-mass spectrometry.
April 05, 2019
News
14
5
3M Drug Delivery Systems UK organization has revealed that it is relocating its R&D team to the Charnwood Campus, which is an officially designated Life Sciences Opportunity Zone in Loughborough, United Kingdom